SHIRE HUMAN GENETIC THERAPIES LIMITED
Company Information
- Company Number
- 04243270
- Registered Address
- 1 Kingdom Street, London, United Kingdom, W2 6BD
- Status
- Dissolved
- Employee Count
- 0
- Turnover
- £0
- EBITDA
- £0
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 28 June 2001
- Nature of Business
- 74990 - Non-trading company
- Industries
- Professional Services
- Region
- London
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 |
Payment Time Trends
Payment Distribution Trends
Company Summary
SHIRE HUMAN GENETIC THERAPIES LIMITED is a biotechnology company that focuses on developing and providing innovative genetic therapies for rare diseases. The company is committed to sustainability and has implemented various initiatives to reduce its environmental impact.
Their sustainability program includes reducing greenhouse gas emissions, conserving water and energy, and promoting waste reduction and recycling. They also prioritize ethical and responsible business practices, including fair labor standards and transparency in supply chain management.
The company's main products and services include gene therapy treatments for rare diseases such as hemophilia, Fabry disease, and Hunter syndrome. They also offer support and education programs for patients and their families.
The key people at SHIRE HUMAN GENETIC THERAPIES LIMITED include the CEO, Mr. Flemming Ornskov, and the Chief Scientific Officer, Dr. Philip J. Vickers. They lead a team of dedicated researchers and scientists who are committed to developing life-changing treatments for patients.
The company can be contacted through their website, www.shire.com, or through their registered office address at 300 Shire Way, Lexington, MA 02421, United States. With their focus on sustainability and dedication to providing innovative genetic therapies, SHIRE HUMAN GENETIC THERAPIES LIMITED is a leading company in the biotechnology industry.
